{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:03:16Z","timestamp":1790420596030,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12020-018-1675-4","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T10:07:50Z","timestamp":1531735670000},"page":"701-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Metyrapone treatment in Cushing\u2019s syndrome: a real-life study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"Filippo","family":"Ceccato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Zilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Albiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Watutantrige-Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sabbadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M. Biller, J.W. Findling et al.The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526\u20131540 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR2","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jc.2009-0612","volume":"94","author":"M Boscaro","year":"2009","unstructured":"M. Boscaro, G. Arnaldi, Approach to the patient with possible Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 94, 3121\u20133131 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-013-0129-2","volume":"47","author":"A Colao","year":"2014","unstructured":"A. Colao, M. Boscaro, D. Ferone, F.F. Casanueva, Managing Cushing\u2019s disease: the state of the art. Endocrine 47, 9\u201320 (2014)","journal-title":"Endocrine"},{"key":"1675_CR4","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"L.K. Nieman, B.M. Biller, J.W. Findling et al.Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 100, 2807\u20132831 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/MED.0b013e3283631809","volume":"20","author":"LK Nieman","year":"2013","unstructured":"L.K. Nieman, Update in the medical therapy of Cushing\u2019s disease. Curr. Opin. Endocrinol. Diabetes Obes. 20, 330\u2013334 (2013)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1675_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1530\/EJE-13-0634","volume":"170","author":"C Dimopoulou","year":"2014","unstructured":"C. Dimopoulou, J. Schopohl, W. Rachinger et al. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing\u2019s disease: care reality in the Munich metropolitan region. Eur. J. Endocrinol. 170, 283\u2013294 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000314299","volume":"92","author":"M Losa","year":"2010","unstructured":"M. Losa, P. Picozzi, M.G. Redaelli, A. Laurenzi, P. Mortini, Pituitary radiotherapy for Cushing\u2019s disease. Neuroendocrinology 92, 107\u2013110 (2010)","journal-title":"Neuroendocrinology"},{"key":"1675_CR8","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1210\/jc.2011-0536","volume":"96","author":"P Kamenick\u00fd","year":"2011","unstructured":"P. Kamenick\u00fd, C. Droumaguet, S. Salenave et al. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 96, 2796\u20132804 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12020-015-0601-2","volume":"52","author":"S Cannav\u00f2","year":"2016","unstructured":"S. Cannav\u00f2, E. Messina, A. Albani et al. Clinical management of critically ill patients with Cushing\u2019s disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide. Endocrine 52, 481\u2013487 (2016)","journal-title":"Endocrine"},{"key":"1675_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/21678707.2015.991714","volume":"3","author":"F Ceccato","year":"2015","unstructured":"F. Ceccato, M. Barbot, M. Zilio, N. Albiger, F. Mantero, C. Scaroni, Therapeutic strategies for Cushing\u2019s syndrome: an update. Expert Opin. Orphan Drugs 3, 45\u201356 (2015)","journal-title":"Expert Opin. Orphan Drugs"},{"key":"1675_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","volume":"35","author":"JA Verhelst","year":"1991","unstructured":"J.A. Verhelst, P.J. Trainer, T.A. Howlett et al. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing\u2019s syndrome. Clin. Endocrinol. 35, 169\u2013178 (1991)","journal-title":"Clin. Endocrinol."},{"key":"1675_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2265.2012.04424.x","volume":"77","author":"E Valassi","year":"2012","unstructured":"E. Valassi, I. Crespo, I. Gich, J. Rodr\u00edguez, S.M. Webb, A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing\u2019s syndrome. Clin. Endocrinol. 77, 735\u2013742 (2012)","journal-title":"Clin. Endocrinol."},{"key":"1675_CR13","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1210\/jc.2015-2616","volume":"100","author":"E Daniel","year":"2015","unstructured":"E. Daniel, S. Aylwin, O. Mustafa et al.Effectiveness of metyrapone in treating Cushing\u2019s syndrome: a retrospective multicenter study in 195 patients. J. Clin. Endocrinol. Metab. 100, 4146\u20134154 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","volume":"17","author":"M Barbot","year":"2014","unstructured":"M. Barbot, N. Albiger, F. Ceccato et al.Combination therapy for Cushing\u2019s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? Pituitary 17, 109\u2013117 (2014)","journal-title":"Pituitary"},{"key":"1675_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-14-0061","volume":"171","author":"F Ceccato","year":"2014","unstructured":"F. Ceccato, G. Antonelli, M. Barbot et al. The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing\u2019s syndrome: the use of a LC-MS\/MS method in routine clinical practice. Eur. J. Endocrinol. 171, 1\u20137 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cca.2015.10.004","volume":"451","author":"G Antonelli","year":"2015","unstructured":"G. Antonelli, F. Ceccato, C. Artusi, M. Marinova, M. Plebani, Salivary cortisol and cortisone by LC-MS\/MS: validation, reference intervals and diagnostic accuracy in Cushing\u2019s syndrome. Clin. Chim. Acta 451, 247\u2013251 (2015)","journal-title":"Clin. Chim. Acta"},{"key":"1675_CR17","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2015-2507","volume":"100","author":"F Ceccato","year":"2015","unstructured":"F. Ceccato, M. Barbot, M. Zilio et al. Screening tests for Cushing\u2019s syndrome: urinary free cortisol role measured by LC-MS\/MS. J. Clin. Endocrinol. Metab. 100, 3856\u20133861 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1161\/01.CIR.88.5.2460","volume":"88","author":"D Perloff","year":"1993","unstructured":"D. Perloff, C. Grim, J. Flack, E.D. Frohlich, M. Hill, M. McDonald, B.Z. Morgenstern, Human blood pressure determination by sphygmomanometry. Circulation 88, 2460\u20132470 (1993)","journal-title":"Circulation"},{"key":"1675_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1515\/cclm-2013-0471","volume":"52","author":"G Antonelli","year":"2014","unstructured":"G. Antonelli, C. Artusi, M. Marinova et al. Cortisol and cortisone ratio in urine: LC-MS\/MS method validation and preliminary clinical application. Clin. Chem. Lab. Med. 52, 213\u2013220 (2014)","journal-title":"Clin. Chem. Lab. Med."},{"key":"1675_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.clinbiochem.2015.12.006","volume":"49","author":"G Antonelli","year":"2016","unstructured":"G. Antonelli, A. Padoan, C. Artusi, M. Marinova, M. Zaninotto, M. Plebani, Automated saliva processing for LC-MS\/MS: improving laboratory efficiency in cortisol and cortisone testing. Clin. Biochem. 49, 518\u2013520 (2016)","journal-title":"Clin. Biochem."},{"key":"1675_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/EJE-12-0534","volume":"167","author":"F Ceccato","year":"2012","unstructured":"F. Ceccato, N. Albiger, G. Reimondo et al. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. Eur. J. Endocrinol. 167, 769\u2013776 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR22","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"G. Arnaldi, A. Angeli, A.B. Atkinson et al. Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593\u20135602 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR23","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1210\/jc.2012-3200","volume":"98","author":"X Bertagna","year":"2013","unstructured":"X. Bertagna, L. Guignat, Approach to the Cushing\u2019s disease patient with persistent\/recurrent hypercortisolism after pituitary surgery. J. Clin. Endocrinol. Metab. 98, 1307\u20131318 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1530\/EJE-07-0514","volume":"158","author":"F Castinetti","year":"2008","unstructured":"F. Castinetti, I. Morange, P. Jaquet, B. Conte-Devolx, T. Brue, Ketoconazole revisited: a preoperative or postoperative treatment in Cushing\u2019s disease. Eur. J. Endocrinol. 158, 91\u201399 (2008)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2013-3628","volume":"99","author":"F Castinetti","year":"2014","unstructured":"F. Castinetti, L. Guignat, P. Giraud et al. Ketoconazole in Cushing\u2019s disease: is it worth a try? J. Clin. Endocrinol. Metab. 99, 1623\u20131630 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1530\/EJE-11-0424","volume":"165","author":"R Bou Khalil","year":"2011","unstructured":"R. Bou Khalil, C. Baudry, L. Guignat et al. Sequential hormonal changes in 21 patients with recurrent Cushing\u2019s disease after successful pituitary surgery. Eur. J. Endocrinol. 165, 729\u2013737 (2011)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-13-0159","volume":"169","author":"F Ceccato","year":"2013","unstructured":"F. Ceccato, M. Barbot, M. Zilio et al. Performance of salivary cortisol in the diagnosis of Cushing\u2019s syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur. J. Endocrinol. 169, 31\u201336 (2013)","journal-title":"Eur. J. Endocrinol."},{"key":"1675_CR28","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.4158\/EP161380.OR","volume":"22","author":"TyB Carroll","year":"2016","unstructured":"Ty.B. Carroll, BradleyR. Javorsky, JamesW. Findling, Postsurgical recurrent Cushing disease: clinical benefit of early intervention in patients with normal urinary free cortisol. Endocr. Pract. 22, 1216\u20131223 (2016)","journal-title":"Endocr. Pract."},{"key":"1675_CR29","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"O.M. Dekkers, E. Horv\u00e1th-Puh\u00f3, J.O. J\u00f8rgensen et al. Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J. Clin. Endocrinol. Metab. 98, 2277\u20132284 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"A. Colao, S. Petersenn, J. Newell-Price et al. A 12-month phase 3 study of pasireotide in Cushing\u2019s disease. N. Engl. J. Med. 366, 914\u2013924 (2012)","journal-title":"N. Engl. J. Med."},{"key":"1675_CR31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1056\/NEJMc1000094","volume":"362","author":"RA Feelders","year":"2010","unstructured":"R.A. Feelders, C. de Bruin, A.M. Pereira et al. Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease. N. Engl. J. Med. 362, 1846\u20131848 (2010)","journal-title":"N. Engl. J. Med."},{"key":"1675_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","volume":"16","author":"R Pas van der","year":"2013","unstructured":"R. van der Pas, C. de Bruin, A.M. Pereira et al. Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease. Pituitary 16, 536\u2013544 (2013)","journal-title":"Pituitary"},{"key":"1675_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12020-016-0978-6","volume":"54","author":"J Findling","year":"2016","unstructured":"J. Findling, M. Fleseriu, J. Newell-Price et al. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing\u2019s disease: 12-month, phase III pasireotide study. Endocrine 54, 516\u2013523 (2016)","journal-title":"Endocrine"},{"key":"1675_CR34","first-page":"3082","volume":"84","author":"L Plat","year":"1999","unstructured":"L. Plat, R. Leproult, M. L\u2019Hermite-Baleriaux et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J. Clin. Endocrinol. Metab. 84, 3082\u20133092 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1675_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11102-011-0333-0","volume":"15","author":"H Raff","year":"2012","unstructured":"H. Raff, Cushing\u2019s syndrome: diagnosis and surveillance using salivary cortisol. Pituitary 15, 64\u201370 (2012)","journal-title":"Pituitary"},{"key":"1675_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40292-016-0153-4","volume":"23","author":"F Ceccato","year":"2016","unstructured":"F. Ceccato, M. Boscaro, Cushing\u2019s syndrome: screening and diagnosis. High Blood Pres. Cardiovasc. Prev. 23, 209 (2016)","journal-title":"High Blood Pres. Cardiovasc. Prev."},{"key":"1675_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cen.12431","volume":"81","author":"R Pivonello","year":"2014","unstructured":"R. Pivonello, S. Petersenn, J. Newell\u2010Price et al. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing\u2019s disease: results from a phase III study. Clin. Endocrinol. 81, 408\u2013417 (2014)","journal-title":"Clin. Endocrinol."},{"key":"1675_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1055\/s-0043-115008","volume":"49","author":"F Ceccato","year":"2017","unstructured":"F. Ceccato, M. Boccato, M. Zilio et al. Body composition is different after surgical or pharmacological remission of Cushing\u2019s syndrome: a prospective DXA study. Horm. Metab. Res. 49, 660\u2013666 (2017)","journal-title":"Horm. Metab. Res."},{"key":"1675_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000314315","volume":"92","author":"MV Cicala","year":"2010","unstructured":"M.V. Cicala, F. Mantero, Hypertension in Cushing\u2019s syndrome: from pathogenesis to treatment. Neuroendocrinology 92, 44\u201349 (2010)","journal-title":"Neuroendocrinology"},{"key":"1675_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/HJH.0000000000000415","volume":"33","author":"A Isidori","year":"2015","unstructured":"A. Isidori, C. Graziadio, R. Paragliola et al. The hypertension of Cushing\u02bcs syndrome: controversies in the pathophysiology and focus on cardiovascular complications. J. Hypertens. 33, 44\u201360 (2015)","journal-title":"J. Hypertens."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1675-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1675-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:24:34Z","timestamp":1563218674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1675-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1675-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"28 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"F.C.: The Ph.D. grant was founded by Novartis. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}